Advertisement
Research Article| Volume 12, ISSUE 4, P723-741, December 1992

Immunosuppressive Effects of Blood Transfusion

  • Dennis M. Smith Jr
    Correspondence
    Address reprint requests to: Dennis M. Smith, Jr, MD, Memorial Laboratories, 3625 University Boulevard, South Jacksonville, FL 32216
    Affiliations
    From the Department of Pathology, Memorial Medical Center of Jacksonville, Jacksonville, Florida
    Search for articles by this author
DOI:https://doi.org/10.1016/S0272-2712(18)30484-0
Immunosuppressive Effects of Blood Transfusion
Previous Articleleukocyte-reduced blood components in transfusion medicine: Current Indications and Prospects for the Future
Next ArticleSpecial Issues in Transfusion Medicine
      This paper is only available as a PDF. To read, Please Download here.
      Various in vitro studies, animal models, and retrospective investigations suggest that blood transfusion modulates the immune system. Not all studies, however, support this trend. This article provides a balanced presentation of the issues surrounding the concept of the immunosuppressive effects of blood transfusion.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

        • Agarwal M.
        • Blumberg N.
        Colon cancer patients transfused perioperatively have an increased incidence of recurrence [abstract].
        Transfusion. 1983; 23: 421
        • Akbar A.N.
        • Fitzgerald-Bocarsly P.A.
        • de Sousa M.
        • et al.
        Decreased natural killer activity in thalassemia major: A possible consequence of iron overload.
        J Immunol. 1986; 136: 1635-1640
        • Akbar A.N.
        • Giardina P.G.
        • Hilgartner M.W.
        • et al.
        Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.
        Clin Exp Immunol. 1985; 62: 397-404
        • Alexander J.W.
        Transfusion-induced immunomodulation and infection.
        Transfusion. 1991; 31: 195-196
        • Beck I.
        • Scott J.S.
        • Pepper M.
        • et al.
        The effect of neonatal exchange and later blood transfusion on lymphocyte cultures.
        Am J Reprod Immunol. 1981; 1: 224-225
        • Bickel K.D.
        • Terasaki K.D.
        • Loew R.
        • et al.
        Effect of blood transfusions on survival after cancer surgery.
        Neth J Med. 1985; 28: 257-258
        • Blair S.D.
        • Janvrin S.B.
        Relation between cancer of the colon and blood transfusion.
        BMJ. 1985; 290: 1516-1517
        • Blumberg N.
        • Agarwal M.
        • Chuang C.
        A possible association between survival time and transfusion in patients with cervical cancer.
        Yale J Biol Med. 1992; (in press)
        • Blumberg N.
        • Agarwal M.
        • Chuang C.
        Relation between recurrence of cancer of the colon and blood transfusion.
        BMJ. 1985; 290: 1037-1039
        • Blumberg N.
        • Heal J.M.
        Perioperative blood transfusion and solid tumor recurrence.
        Cancer Invest. 1987; 5: 615-625
        • Blumberg N.
        • Heal J.M.
        Perioperative blood transfusion and solid tumour recurrence.
        Blood Rev. 1987; 1: 219-229
        • Blumberg N.
        • Heal J.M.
        Renal allograft survival in transfused and non-transfused patients.
        Lancet. 1988; 1: 946
        • Blumberg N.
        • Heal J.M.
        Time to abandon pre-transplant blood transfusion?.
        Lancet. 1988; 1: 567-568
        • Blumberg N.
        • Heal J.M.
        Transfusion and host defenses against cancer recurrence and infection.
        Transfusion. 1989; 29: 236-245
        • Blumberg N.
        • Heal J.M.
        Transfusion and recipient immune function.
        Arch Pathol Lab Med. 1989; 113: 246-253
        • Blumberg N.
        • Heal J.M.
        • Murphy P.
        • et al.
        The association between number of red cell transfusions and cancer recurrence suggests a dose-response relationship [abstract].
        Blood. 1986; 68 (suppl 1): 294A
        • Blumberg N.
        • Heal J.M.
        • Murphy P.
        • et al.
        Association between transfusion of whole blood and recurrence of cancer.
        BMJ. 1986; 293: 530-533
        • Blumberg N.
        • Heal J.M.
        • Murphy P.
        • et al.
        Further evidence supporting a cause and effect relationship between blood transfusion and earlier cancer recurrence.
        Ann Surg. 1988; 207: 410-415
        • Blumberg N.
        • Triulzi D.J.
        • Heal J.M.
        Transfusion-induced immunomodulation and its clinical consequences.
        Transfusion Med Rev. 1990; 4: 24-35
        • Bock M.
        • Grevers G.
        • Koblitz M.
        • et al.
        Influence of blood transfusion on recurrence, survival and postoperative infections of laryngeal cancer.
        Acta Otolaryngol (Stockh). 1990; 110: 155-160
        • Boshkov L.K.
        • Kelton J.G.
        Use of intravenous gammaglobulin as an immune replacement and an immune suppressant.
        Transfusion Med Rev. 1989; 3: 82-120
        • Brettler D.B.
        • Brewster F.
        • Levine P.H.
        • et al.
        Immunologic aberrations, HIV seropositivity and seroconversion rates in patient with hemophilia B.
        Blood. 1987; 70: 276-281
        • Brettler D.B.
        • Forsberg A.D.
        • Brewster F.
        • et al.
        Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate.
        Am J Med. 1986; 81: 607-611
        • Brieva J.A.
        • Sequi J.
        • Zabay J.M.
        • et al.
        Abnormal B cell function in haemophiliacs and their relationship with factor concentrates administration.
        Clin Exp Immunol. 1985; 59: 491-498
        • Brunson M.E.
        • Alexander J.W.
        Mechanisms of transfusion induced immunosuppression.
        Transfusion. 1990; 30: 651-658
        • Bryan C.F.
        • Leech S.H.
        The immunoregulatory nature of iron. I. Lymphocyte proliferation.
        Cell Immunol. 1983; 2: 681-682
        • Burlingham W.J.
        • Sparks E.M.F.
        • Heatley G.A.
        • et al.
        Mechanism of action of donor-specific transfusion: Inhibition of mixed lymphocyte culture response by patient plasma.
        Transplant Proc. 1984; 16: 1451-1453
        • Burlingham W.J.
        • Sparks E.M.F.
        • Sondel P.M.
        • et al.
        Improved renal allograft survival following donor-specific transfusions.
        Transplantation. 1985; 39: 12-17
        • Burlingham W.J.
        • Sparks-Mackety E.M.F.
        • Wendel T.
        • et al.
        Beneficial effect of pretransplant donor-specific transfusions: Evidence for an idiotype network mechanism.
        Transplant Proc. 1985; 17: 2376-2379
        • Burrows L.
        • Tartter P.
        Effect of blood transfusions on colonic malignancy recurrence rate.
        Lancet. 1982; 2: 662
        • Burrows L.
        • Tartter P.
        • Aufses A.
        Increased recurrence rates in perioperatively transfused colorectal malignancy patients.
        Cancer Detect Prev. 1987; 10: 361-369
        • Carpenter N.
        • Benzonana G.
        • Jeannet M.
        • et al.
        Association of a better kidney graft survival with the presence of circulating immune complexes before transplantation.
        Transplantation. 1982; 33: 181-183
        • Cheigh J.S.
        • Suthanthiran M.
        • Kaplan M.
        • et al.
        Induction of immune alterations and successful renal transplantation with a simplified method of donor-specific blood transfusion.
        Transplantation. 1984; 38: 501-506
        • Choremi H.
        • Sidiri E.
        • Psarra K.
        • et al.
        Immune status of Greek patients with betathalassemia major negative for anti-HIV.
        Blut. 1987; 54: 267-273
        • Corman J.
        • Arnoux R.
        • Peloquin A.
        • et al.
        Blood transfusions and survival after colectomy for colorectal cancer.
        Can J Surg. 1986; 29: 325-329
        • Creasy T.S.
        • Veitch P.S.
        • Bell P.R.
        A relationship between perioperative blood transfusion and recurrence of carcinoma of the sigmoid colon following potentially curative surgery.
        Ann R Coll Surg Engl. 1987; 69: 100-103
        • Dalrymple J.C.
        • Monaghan J.M.
        Recurrent carcinoma of the vulva: Relationship with operative blood transfusion.
        J Obstet Gynecol. 1986; 7: 65-67
        • Dawes L.G.
        • Aprahamian C.
        • Condon R.E.
        • et al.
        The risk of infection after colon injury.
        Surgery. 1986; 100: 796-803
        • De Martino M.
        • Quarta G.
        • Melpignano A.
        • et al.
        Antibodies to HTLV-III and the lymphadenopathy syndrome in multitransfused beta-thalassemia patients.
        Vox Sang. 1985; 9: 230-233
        • De Martino M.
        • Rossi M.E.
        • Muccioli A.T.
        • et al.
        Altered T cell subsets and function in poly-transfused beta-thalassemia patients: Correlation with sex and age at first transfusion.
        Vox Sang. 1985; 48: 296-304
        • DeShazo R.D.
        • Daul C.B.
        • Andes W.A.
        • et al.
        A longitudinal immunologic evaluation of hemophiliac patients.
        Blood. 1985; 66: 993-998
        • DeSousa M.
        Blood transfusions and allograft survival: Iron-related immunosuppression [letter]?.
        Lancet. 1983; 2: 681-682
        • Dossetor J.B.
        • MacKinnon K.J.
        • Gault M.H.
        • et al.
        Cadaver kidney transplants.
        Transplantation. 1967; 5: 844-853
        • Easterbrook P.J.
        • Berlin J.A.
        • Gopalan R.
        • et al.
        Publication bias in clinical research.
        Lancet. 1991; 337: 867-872
        • Edelbaum D.N.
        No AIDS among patients on dialysis?.
        N Engl J Med. 1986; 314: 187
        • Eibl M.M.
        • Ahmad R.
        • Wolf H.M.
        • et al.
        A component of factor VIII preparations which can be separated from factor VIII activity down modulates human monocyte functions.
        Blood. 1987; 69: 1153-1160
        • Engelhard D.
        • Waner J.L.
        • Kapoor N.
        • et al.
        Effect of intravenous immune globulin on natural killer cell activity: Possible associations with autoimmune neutropenia and idiopathic thrombocytopenia.
        J Pediatr. 1986; 108: 77-81
        • Fabre J.W.
        • Morris P.J.
        The effect of donor strain blood pretreatment on renal allograft rejection in rats.
        Transplantation. 1972; 14: 608-617
        • Fagiolo U.
        • Corsano A.
        • Zanon G.F.
        • et al.
        Transfusion of blood components and skin allograft survival in rabbits.
        Transplant Proc. 1979; 11: 1446-1447
        • Fehrman I.
        • Ringden O.
        Lymphocytes from multitransfused uremic patients have poor MLC reactivity.
        Tissue Antigens. 1981; 17: 386-395
        • Fehrman I.
        • Ringden O.
        Reduced immunologic responsiveness in multitransfused anemic nonuremic patients.
        Transplant Proc. 1982; 14: 341-343
        • Fischer E.
        • Lenhard V.
        • Seifert P.
        • et al.
        Blood transfusion-induced suppression of cellular immunity in man.
        Hum Immunol. 1980; 3: 187-194
        • Foegh M.L.
        Immune regulation by eicosanoids.
        Transplant Proc. 1988; 20: 1158-1161
        • Ford C.D.
        • Warnick C.T.
        • Sheets S.
        • et al.
        Blood transfusion lower natural killer cell activity.
        Transplant Proc. 1987; 19: 1456-1457
        • Foster Jr, R.S.
        • Costanza M.C.
        • Foster J.C.
        • et al.
        Adverse relationship between blood transfusions and survival after colectomy for colon cancer.
        Cancer. 1985; 55: 1195-1201
        • Foster Jr, R.S.
        • Foster J.C.
        • Costanza M.C.
        Blood transfusions and survival after surgery for breast cancer.
        Arch Surg. 1984; 119: 1138-1140
        • Francis D.M.A.
        • Judson R.T.
        Blood transfusion and recurrence of cancer of the colon and rectum.
        Br J Surg. 1987; 74: 26-30
        • Francis D.M.A.
        • Shenton B.K.
        Blood transfusion and tumor growth: Evidence from laboratory animals [letter].
        Lancet. 1981; 2: 871
        • Francis D.M.A.
        • Shenton B.K.
        • Roung G.
        • et al.
        Tumor growth and blood transfusion.
        Exp Clin Cancer Res. 1982; 1: 121-126
        • Francis D.M.S.
        • Burren C.P.
        • Clunie G.J.A.
        Acceleration of B16 melanoma growth in mice after blood transfusion.
        Surgery. 1987; 102: 485-492
        • Frankish P.D.
        • McNee R.K.
        • Alley P.G.
        • et al.
        Relation between cancer of the colon and blood transfusion.
        BMJ. 1985; 290: 1827
        • Freedman J.
        • Mazaheri R.
        • Read S.
        • et al.
        Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2 year period.
        Diagn Clin Immunol. 1987; 5: 30-40
        • Fry R.D.
        • Fleshman J.W.
        • Kodner I.J.
        Effect of perioperative blood transfusion on recurrence of Chrohn’s disease.
        Lancet. 1989; 2: 1048
        • Gascon P.
        • Scala G.
        • Djeu J.
        • et al.
        Decreased lymphokine and monokine production in hyper-transfused patients [abstract].
        Blood. 1986; 68: 297A
        • Gascon P.
        • Zoumbos N.C.
        • Young N.S.
        Immunologic abnormalities in patients receiving multiple blood transfusions.
        Ann Intern Med. 1984; 100: 173-177
        • George C.D.
        • Morello P.J.
        Immunologic effects of blood transfusion upon renal transplantation tumor operations and bacterial infections.
        Am J Surg. 1986; 152: 329-337
        • Gerbase-DeLima M.
        • Frugiuele F.S.
        • Lieber S.R.
        • et al.
        Cellular immunity in multitransfused nonuremic patients.
        Transplant Proc. 1985; 17: 2432-2434
        • Gjerset G.F.
        • Martin P.J.
        • Counts R.B.
        • et al.
        Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate.
        Blood. 1984; 64: 715-720
        • Goicoa M.A.
        • Estevez M.E.
        • Ballart I.J.
        • et al.
        Impairment of natural killer (NK) function in carriers and patients with thalassemia major.
        Nouv Rev Fr Hematol. 1986; 28: 75-79
        • Goldsmith J.C.
        • Moseley P.K.
        • Monick M.
        • et al.
        T-lymphocyte subpopulation abnormalities in apparently healthy patients with hemophilia.
        Ann Intern Med. 1983; 98: 294-296
        • Goodwin J.S.
        • Bankhurst A.D.
        • Messner R.P.
        Suppression of human T-cell mitogenesis by prostaglandin: Existence of a prostaglandin-producing suppressor cell.
        J Exp Med. 1977; 146: 1719-1734
        • Gorski A.
        • Gjerset G.F.
        • Martin P.J.
        • et al.
        Abnormal B-cell function in hemophiliacs treated with cryoprecipitate and factor VIII and IX concentrates.
        Clin Immunol Immunopathol. 1986; 40: 447-455
        • Halasz N.A.
        • Orloff M.J.
        • Hirose F.
        Increased survival of renal homografts in dogs after injection of graft donor blood.
        Transplantation. 1964; 2: 453-458
        • Hasek M.
        • Chutna J.
        • Holan V.
        • et al.
        Induction of transplantation tolerance using serum as antigen source.
        Nature. 1976; 262: 295-296
        • Heal J.M.
        • Chuang C.
        • Blumberg N.
        Perioperative blood transfusions and prostate cancer recurrence and survival.
        Am J Surg. 1988; 156: 374-379
        • Hollan S.R.
        • Fust G.
        • Nagy K.
        • et al.
        Immunological alterations in anti-HTLV-III negative haemophiliacs and homosexual men in Hungary.
        Immunol Lett 11 FOSSIO. 1985;
        • Horimi T.
        • Kagawa S.
        • Ninomiya M.
        • et al.
        Possible induction by blood transfusion of immunological tolerance against growth of transplanted tumors in mice.
        Acta Med Okayama. 1983; 37: 259-363
        • Horimi T.
        • Terasaki P.
        • Chia D.
        • et al.
        Factors influencing the paradoxical effect of transfusions on kidney transplants.
        Transplantation. 1983; 35: 320-323
        • Hyman N.H.
        • Foster Jr, R.S.
        • DeMeules J.E.
        • et al.
        Blood transfusions and survival after lung cancer resection.
        Am J Surg. 1985; 149: 502-507
        • Jackson V.
        • Tsakiris D.
        • Tonner E.
        • et al.
        In vitro prostaglandin E production following multiple blood transfusions in dialysis patients.
        Transplant Proc. 1985; 17: 2386-2388
        • Jason J.
        • Hilgartner M.
        • Holman R.C.
        • et al.
        Immune status of blood product recipients.
        JAMA. 1985; 253: 1140-1145
        • Jeekel J.
        • Eggermont A.M.M.
        • Heystek G.A.
        • et al.
        Inhibition of tumor growth by blood transfusion in the rat.
        Eur Surg Res. 1982; 14: 124-125
        • Jeffery J.R.
        • Cheung K.
        • Masniuk J.
        • et al.
        Mixed lymphocyte culture responses.
        Transplantation. 1984; 38: 42-45
        • Jenkins A.M.
        • Woodruff M.F.A.
        The effect of prior administration of donor strain blood or blood constituents on the survival of cardiac allografts in rats.
        Transplantation. 1971; 12: 57-60
        • Jerne N.K.
        Towards a network theory of the immune system.
        Ann Immunol (Paris). 1974; 125C: 373-389
        • Johnson J.T.
        • Taylor F.H.
        • Thearle P.B.
        Blood transfusion and outcome in stage III head and neck carcinoma.
        Arch Otolaryngol Head Neck Surg. 1987; 113: 307-310
        • Jones M.C.
        • Power D.A.
        • Cunningham C.
        • et al.
        The influence of repeated transfusion and cyclosporine on secondary alloantibody responses in inbred rats.
        Transplantation. 1988; 45: 1094-1099
        • Kaneda M.
        • Horimi T.
        • Ninomiya M.
        • et al.
        Adverse effect of blood transfusions on survival of patients with gastric cancer.
        Transfusion. 1987; 27: 375-377
        • Kaplan J.
        • Sarnaik S.
        • Gitlin J.
        • et al.
        Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions.
        Blood. 1983; 64: 308-310
        • Kaplan J.
        • Sarnaik S.
        • Levy J.
        Transfusion-induced immunologic abnormalities not related to AIDS virus.
        N Engl J Med. 1985; 313: 1227
        • Katz M.R.
        • Barnhart G.R.
        • Goldman M.H.
        • et al.
        Pretransplant transfusions in cardiac allograft recipients.
        Transplantation. 1987; 43: 499-501
        • Kawada K.
        • Terasaki P.I.
        Evidence for immunosuppression by high-dose gammaglobulin.
        Exp Hematol. 1987; 15: 133-136
        • Kekow J.
        • Plendi H.
        • Gross W.L.
        Abnormal B cell response to T cell-independent polyclonal B cell activators in haemophilia A.
        Clin Exp Immunol. 1986; 64: 376-381
        • Keown P.A.
        • Descamps B.
        Improved renal allograft survival after blood transfusion: A nonspecific, erythrocyte-mediated immunoregulatory process?.
        Lancet. 1979; 1: 20-22
        • Keown P.
        • Descamps B.
        Suppression de la reaction lymphocytaire mixte par des globules rouges autologues et leurs constituants: Une hypothese nouvelle sur Teffet apparemment tolerogene des transfusions sanguines en transplantation.
        CR Acad sci. 1978; 287: 749-752
        • Kerman R.H.
        • Agostino G.
        • van Buren C.T.
        • et al.
        Effect of blood transfusion on graft survival and immune responsiveness.
        Transplant Proc. 1983; 15: 1022-1025
        • Kerman R.
        • Van Buren C.T.
        • Lewis R.M.
        • et al.
        The impact of HLA A, B, and DR blood transfusion and immune responder status on cardiac allograft recipients treated with cyclosporine.
        Transplantation. 1988; 45: 333-337
        • Kieckbusch M.E.
        • O’Fallon J.R.
        • Ahmann D.L.
        • et al.
        Blood transfusion exposure does not influence survival in patients with carcinoma of the breast.
        Transfusion. 1989; 29: 500-504
        • Kimberly R.P.
        • Inman R.D.
        • Bussei J.B.
        • et al.
        Modulation of mononuclear phagocyte system function and circulating immune complexes by lyophilized concentrates in patients with classic hemophilia.
        Clin Immunol Immunopathol. 1984; 31: 321-330
        • Klatzmann D.
        • Gluckman J.C.
        • Chapuis F.
        • et al.
        Suppression of lymphocyte reactivity by blood transfusions in uremic patients.
        Transplantation. 1984; 38: 222-226
        • Kreiss J.K.
        • Kitchen L.W.
        • Prince H.E.
        • et al.
        Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects.
        Am J Med. 1986; 80: 345-350
        • Lagaaij E.L.
        • Hennemann I.P.H.
        • Ruigrok M.
        • et al.
        Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusion on survival of heart and kidney allografts.
        N Engl J Med. 1989; 321: 701-705
        • Landay A.
        • Poon M.C.
        • Abo T.
        • et al.
        Immunologic studies in asymptomatic hemophilia patients.
        J Clin Invest. 1983; 71: 1500-1504
        • Lechner K.
        • Niessner H.
        • Bettelheim P.
        • et al.
        T-cell alterations in hemophiliacs treated with commercial clotting factor concentrates.
        Thromb Haemost. 1983; 50: 552-556
        • Lederman M.M.
        • Ratnoff O.D.
        • Scillian J.J.
        • et al.
        Impaired cell-mediated immunity in patients with classic hemophilia.
        N Engl J Med. 1983; 308: 83-86
        • Lederman M.M.
        • Saunders C.
        • Toossi Z.
        • et al.
        Antihemophilic factor (factor VIII preparations inhibit lymphycyte proliferation and production of interleukin-2).
        J Lab Clin Med. 1986; 197: 471-478
        • Lee C.A.
        • Bofill M.
        • Janossy G.
        • et al.
        Relationships between blood product exposure and immunological abnormalities in English haemophiliacs.
        Br J Haematol. 1985; 60: 161-172
        • Lee C.A.
        • Kernoff P.B.A.
        • Karayiannis P.
        • et al.
        Abnormal T-lymphocyte subsets in hemophilia: Relation to HLA proteins in plasma products.
        N Engl J Med. 1984; 310: 1058
        • Lefrere J.J.
        • Girot R.
        HIV infection in polytransfused thalassaemic patients.
        Lancet. 1987; 2: 686
        • Lehne C.
        • de Cespedes G.M.
        • Vazquez L.
        • et al.
        Blood transfusion effect on T4/T8 cell ratio in renal transplant patients.
        Transplantation. 1984; 17: 2435-2439
        • Leikola J.
        • Myllyla G.
        The clinical use of red blood cell components.
        in: Summers S.H. Smith D.M. Agraneklo V.A. Transfusion Therapy: Guidelines for Practice. American Association of Blood Banks, Arlington, VA1990: 1-25
        • Leivestad T.
        • Thorsby E.
        Effects of HLA-haploidentical blood transfusions on donor-specific immune responsiveness.
        Transplantation. 1984; 37: 175-181
        • Lenhard V.
        • Gemsa D.
        • Opelz G.
        Transfusion-induced release of prostaglandin E2 and its role in the activation of T suppressor cells.
        Transplant Proc. 1985; 17: 2380-2382
        • Lenhard V.
        • Maassen G.
        • Opelz G.
        Transfusion-induced enhancement of prostaglandin and thromboxane release in prospective kidney graft recipients.
        Proc Eur Dial Transplant Assoc Eur Ren Assoc. 1984; 21: 923-927
        • Luban N.L.
        • Kelleher Jr, J.F.
        • Reaman G.H.
        Altered distribution of T-lymphocyte subpopulations in children and adolescents with haemophilia.
        Lancet. 1983; 1: 503-505
        • MacLeod A.M.
        • Mason R.J.
        • Stewart K.N.
        Association of Fc receptor-blocking antibodies and human renal transplant survival.
        Transplantation. 1982; 34: 273-279
        • Macleod A.M.
        • Mather A.
        • Hillis A.N.
        • et al.
        Effect of cyclosporine, previous thirdparty transfusion, and pregnancy on antibody development after donor-specific transfusion before renal transplantation.
        Lancet. 1987; 1: 416-418
        • Madhok R.
        • Gracie A.
        • Lowe G.D.O.
        • et al.
        Impaired cell mediated immunity in haemophilia in the absence of infection with human immunodeficiency virus.
        BMJ. 1986; 293: 978-980
        • Manyonda I.T.
        • Shaw D.E.
        • Foulkes A.
        • et al.
        Renal cell carcinoma: Blood transfusion and survival.
        BMJ. 1986; 293: 537-538
        • Margulies M.
        • Voto L.S.
        • Mathet E.
        • et al.
        High-dose intravenous IgG for the treatment of severe rhesus alloimmunization.
        Vox Sang. 1991; 61: 181-189
        • Marquet R.L.
        • de Bruin R.W.F.
        • Dallinga R.J.
        • et al.
        Modulation of tumor growth by allogeneic blood transfusion.
        J Cancer Res Clin Oncol. 1986; 3: 50-53
        • Marquet R.
        • Heystek G.
        • Niessen G.
        • et al.
        Induction of suppressive cells by a single blood transfusion in rats.
        Transplant Proc. 1982; 14: 397-399
        • Marquet R.L.
        • Heystek G.A.
        • Tinbergen W.J.
        Specific inhibition of organ allograft rejection by donor blood.
        Transplant Proc. 1971; 3: 708-710
        • Martin D.C.
        • Dowdy S.F.
        • Hewitt C.
        • et al.
        Comparison of renal allograft survival in rats pretreated with multiple blood transfusion combined with either cyclosporine or azathioprine.
        Transplant Proc. 1985; 17: 1087-1090
        • Martin D.C.
        • Hewitt C.W.
        Enhancement of rat renal allografts with various immunogens.
        Invest Urol. 1981; 18: 406-408
        • Matheson D.S.
        • Green B.J.
        • Fritzler M.J.
        • et al.
        Humoral immune response in patients with hemophilia.
        Clin Immunol Immunopathol. 1987; 4: 41-50
        • Matheson D.S.
        • Green B.J.
        • Poon M.C.
        • et al.
        Natural killer cell activity from hemophiliacs exhibits differential responses to various forms of interferon.
        Blood. 1986; 67: 164-167
        • Matsumoto T.
        • Sakagami K.
        • Tsuboi K.
        • et al.
        Possible mechanism of donor-specific blood transfusions in prolongation of kidney graft survival.
        Transplant Proc. 1985; 17: 2401-2406
        • McDonald C.
        • Jackson V.
        • Kilpatrick D.C.
        • et al.
        A diffusable factor in Scottish coagulation factor concentrates can inhibit lymphocyte transformation in vitro.
        Vox Sang. 1985; 49: 187-194
        • Menitove J.E.
        • Aster R.H.
        • Casper J.T.
        • et al.
        T-lymphocyte subpopulations in patients with classic hemophilia.
        N Engl J Med. 1983; 308: 79-83
        • Meryman H.T.
        Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion.
        Transfusion Med Rev. 1989; 3: 180-193
        • Miholic J.
        • Hudec M.
        • Domanig E.
        • et al.
        Risk factors for severe operations: Analysis of 246 cases by logistic regression.
        Ann Thorac Surg. 1985; 40: 224-228
        • Mikulin T.
        • Powell C.S.
        • Urwin G.H.
        • et al.
        Relation between blood transfusion and survival in renal adenocarcinoma [abstract].
        Br J Surg. 1986; 73: 1036-1037A
        • Moffat E.H.
        • Bloom A.L.
        • Jones J.
        • et al.
        A study of cell mediated and humoral immunity in haemophilia and related disorders.
        Br J Haematol. 1985; 61: 157-167
        • Moffat L.E.F.
        • Sunderland G.T.
        • Lamont D.
        Blood transfusion and survival following nephrectomy for carcinoma of the kidney.
        Br J Urol. 1987; 60: 316-319
        • Mohanakumar T.
        • Ellis T.M.
        • Mendez-Picon G.
        • et al.
        Monitoring human T-cell subpopulations: Effects of immunosuppressive therapy and blood transfusion on OKT4 + /OKT8+ ratios.
        Transplant Proc. 1983; 15: 1978-1979
        • Murphy P.
        • Heal J.M.
        • Blumberg N.
        Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions.
        Transfusion. 1991; 31: 212-217
        • Nanishi F.
        • Inenaga T.
        • Onoyama K.
        • et al.
        Immune alterations in hemodialyzed patients. I. Effect of blood transfusion on T-lymphocyte subpopulations in hemodialyzed patients.
        J Clin Lab Immunol. 1986; 19: 167-174
        • Nathanson S.D.
        • Fox B.A.
        • Westrick P.W.
        • et al.
        Effects of allogeneic blood transfusion in C57 BL/6 mice with and without melanomas [abstract].
        Proc Am Assoc Cancer Res. 1984; 25: 270
        • Nathanson S.D.
        • Tilley B.C.
        • Schultz L.
        • et al.
        Perioperative allogeneic blood transfusions: Survival in patients with resected carcinomas of the colon and rectum.
        Arch Surg. 1985; 120: 734-738
        • Nichols R.L.
        • Smith J.W.
        • Klein D.B.
        • et al.
        Risk of infection after penetrating abdominal trauma.
        N Engl J Med. 1984; 311: 1065-1070
        • Novelli V.M.
        • Mostafavipour H.
        • Abulaban M.
        • et al.
        High prevalence of human immunodeficiency virus infection in children with thalassemia exposed to blood imported from the United States.
        Pediatr Infect Dis J. 1987; 6: 765-766
        • Nowak M.M.
        • Ponsky J.L.
        Blood transfusion and disease-free survival in carcinoma of the breast.
        J Surg Oncol. 1984; 27: 124-130
        • Oikawa T.
        • Hosokawa M.
        • Imamura M.
        • et al.
        Anti-tumor immunity by normal allogeneic blood transfusion in the rat.
        Clin Exp Immunol. 1977; 27: 549-554
        • Opelz G.
        Comparison of the transfusion effect in North America and Europe.
        Transplant Proc. 1988; 20: 1069-1070
        • Opelz G.
        • Mickey M.R.
        • Terasaki P.I.
        Identification of unresponsive kidney-transplant recipients.
        Lancet. 1972; 1: 868-871
        • Opelz G.
        • Sengar D.P.S.
        • Mickey M.R.
        • et al.
        Effect of blood transfusion on subsequent kidney transplants.
        Transplant Proc. 1973; 5: 253-259
        • Ota D.
        • Alvarez L.
        • Lichtiger B.
        • et al.
        Perioperative blood transfusions in patients with colon carcinoma.
        Transfusion. 1985; 25: 392-394
        • Ottilo G.
        • De Paulis R.
        • Pansini S.
        • et al.
        Major sternal wound infection after open-heart surgery: A multivariate analysis of risk factors in 2579 consecutive procedures.
        Ann Thorac Surg. 1987; 44: 173-179
        • Padberg W.M.
        • Lord R.H.
        • Araneda D.
        • et al.
        Synergistic immunosuppressive effect of subtherapeutic doses of cyclosporine A on immunologic enhancement in rat recipients of cardiac allografts.
        Transplant Proc. 1988; 20 (suppl 3): 1053-1056
        • Pardalos G.
        • Kanakoudi-Tsakalidis F.
        • Malaka-Zafiriu M.
        • et al.
        Iron-related disturbances of cell-mediated immunity in multitransfused children with thalassemia major.
        Clin Exp Immunol. 1987; 68: 138-145
        • Park R.H.R.
        • Russell R.I.
        Blood transfusion—primary therapy for inflammatory bowel disease?.
        Gut. 1988; 29: A709
        • Park R.
        • Russell R.
        Effect of perioperative blood transfusion on recurrence of Crohn’s disease.
        Lancet. 1989; 2: 631
        • Parrott N.R.
        • Lennard T.W.J.
        • Taylor R.M.R.
        • et al.
        Effect of perioperative blood transfusion on recurrence of colorectal cancer.
        Br J Surg. 1986; 73: 970-973
        • Pastorino U.
        • Valente M.
        • Cataldo I.
        • et al.
        Perioperative blood transfusion and prognosis of resected stage la lung cancer.
        Eur J Cancer Clin Oncol. 1986; 22: 1375-1378
        • Perez R.V.
        • Heyd T.J.
        • Munda R.
        • et al.
        Induction of long-term rat cardiac allograft survival in rats with multiple donor specific transfusions and cyclosporine.
        Curr Surg. 1988; 45: 9-12
        • Persijn G.G.
        • Hendriks G.F.J.
        • van Rood J.J.
        HLA matching, blood transfusion and renal transplantation.
        Clin Immunol Allergy. 1984; 4: 535-565
        • Pinto V.
        • Baldonedo R.
        • Nicholas C.
        • et al.
        Relationship of transfusion and infectious complications after gastric carcinoma operations.
        Transfusion. 1991; 31: 114-118
        • Podolsky D.K.
        Inflammatory bowel disease.
        N Engl J Med. 1991; 325: 928-937
        • Pollack S.
        • Atias D.
        • Yoffe G.
        • et al.
        Impaired immune function in hemophilia patients treated exclusively with cryoprecipitate: Relation to duration of treatment.
        Am J Hematol. 1985; 20: 1-6
        • Proud G.
        • Shenton B.K.
        • Smith B.M.
        Blood transfusion and renal transplantation.
        Br J Surg. 1979; 66: 678-682
        • Quintiliana L.
        • Buzzonetti A.
        • DiGirolamo M.
        • et al.
        Effects of blood transfusion on the immune responsiveness and survival of cancer patients: A prospective study.
        Transfusion. 1991; 31: 713-718
        • Quintiliani L.
        • Martini F.
        • Buzzonetti A.
        • et al.
        Blood transfusion effect in the syngeneic tumor growth in mice.
        Transfus Sangue. 1987; 32: 76-84
        • Ragni M.V.
        • Winkelstein A.
        • Evans T.L.
        • et al.
        T lymphocyte colony assay in hemophiliacs.
        Blood. 1984; 64: 105-109
        • Riggio R.R.
        • Cheigh J.S.
        • Stenzel K.H.
        • et al.
        Kidney transplant: Use of gamma globulin as an immunosuppressive agent.
        NY State J Med. 1980; 80: 1561-1563
        • Robert-Guroff M.
        • Giardina P.J.
        • Robey W.G.
        • et al.
        HTLV-III neutralizing antibody development in transfusion-dependent seropositive patients with B-thalassemia.
        J Immunol. 1987; 138: 3731-3736
        • Rosenberg S.A.
        • Seipp C.A.
        • White D.E.
        • et al.
        Perioperative blood transfusions are associated with increased rates of recurrence and decreased survival in patients with high-grade soft-tissue sarcomas of the extremities.
        J Clin Oncol. 1985; 3: 698-709
        • Ross W.B.
        Blood transfusion and colorectal cancer.
        J R Coll Surg Edinb. 1987; 32: 197-201
        • Roy R.
        • Lachance J.G.
        • Noel R.
        • et al.
        Improved renal allograft function and survival following nonspecific blood transfusions.
        Transplantation. 1986; 41: 640-643
        • Salvatierra Jr, O.
        • Vincenti F.
        • Amend W.
        • et al.
        Deliberate donor-specific blood transfusion prior to living related renal transplantation.
        Ann Surg. 1980; 192: 543-552
        • Sanfilippo F.
        • Crawford J.
        • Ness G.
        • et al.
        Influence of donor-specific blood transfusions on host cellular immune responsiveness.
        Transplant Proc. 1986; 18: 692-694
        • Schot J.D.L.
        • Schuurman R.K.B.
        Blood transfusion suppresses cutaneous cell-mediated immunity.
        Clin Exp Immunol. 1986; 65: 336-344
        • Schriemer P.A.
        • Longnecker D.E.
        • Mintz P.D.
        The possible immunosuppressive effects of perioperative blood transfusion in cancer patients.
        Anesthesiology. 1988; 68: 422-429
        • Schultz J.C.
        • Shahidi N.T.
        Influence of fibronectin-containing blood products on lymphocyte reactivity.
        Transfusion. 1990; 30: 799-807
        • Schultz J.C.
        • Shahidi N.T.
        Inhibition of human lymphocyte reactivity by plasma fibronection in vitro.
        Transfusion. 1990; 30: 791-798
        • Scott A.D.N.
        • Ritchie J.K.
        • Phillips R.K.S.
        Blood transfusion and recurrent Crohn’s disease.
        Br J Surg. 1991; 78: 455-458
        • Sharp R.A.
        • Moreley S.M.
        • Beck J.S.
        • et al.
        Unresponsiveness to skin testing with bacterial antigens in patients with haemophilia A not apparently infected with human immunodeficiency virus (HIV).
        J Clin Pathol. 1987; 40: 849-852
        • Singal D.P.
        • Fagnilli L.
        • Joseph S.
        Blood transfusions induce antiidiotypic antibodies in renal transplant patients.
        Transplant Proc. 1983; 15: 1005-1008
        • Singal D.P.
        • Ludwin D.
        • Blajchman M.A.
        Annotation: Blood transfusion and renal transplantation.
        Br J Haematol. 1985; 61: 595-602
        • Singh S.K.
        • Marquet R.L.
        • de Bruin R.W.F.
        • et al.
        Promotion of tumor growth by blood transfusion.
        Transplant Proc. 1987; 19: 1473-1474
        • Singh S.K.
        • Marquet R.L.
        • Westbroek D.L.
        • et al.
        Enhanced growth of artificial tumor metastases following blood transfusion: The effect of erythrocytes, leukocytes, and plasma transfusion.
        Eur J Cancer Clin Oncol. 1987; 23: 1537-1540
        • Smith M.D.
        • Williams J.D.
        • Coles G.A.
        • et al.
        Blood transfusions, suppressor T cells, and renal transplant survival.
        Transplantation. 1983; 36: 647-650
        • Smolen J.S.
        • Bettelheim P.
        • Koller U.
        • et al.
        Deficiency of the autologous mixed lymphocyte reaction in patients with classic hemophilia treated with commercial factor VIII concentrate.
        J Clin Invest. 1985; 75: 1828-1834
        • Snell G.D.
        • Smith P.
        • Fink M.A.
        Enhancement of the growth of tumor homiotransplants in mice produced by the intravenous injection of donor whole blood.
        Proc Am Assoc Cancer Res. 1955; 2: 47
        • Snyder D.S.
        • Beller D.I.
        • Unanue E.R.
        Prostaglandins modulate macrophage la expression.
        Nature. 1981; 299: 163-165
        • Stein S.F.
        • Evatt B.L.
        • McDougal J.S.
        • et al.
        A longitudinal study of patients with hemophilia: Immunologic correlates of infection with HTLV-III/LAV and other viruses.
        Blood. 1985; 66: 973-979
        • Stephan R.N.
        • Kisala J.M.
        • Dean R.E.
        • et al.
        Effect of blood transfusion on antigen presentation function and on interleukin-2 generation.
        Arch Surg. 1988; 123: 235-240
        • Sullivan J.L.
        • Brewster F.E.
        • Brettler D.B.
        • et al.
        Hemophiliac immunodeficiency: Influence of exposure to factor VIII concentrate, LAV/HTLV-III and herpesviruses.
        J Pediatr. 1986; 108: 504-510
        • Sutherland L.R.
        • Ramcharan S.
        • Bryant H.
        • et al.
        Effect of perioperative blood transfusion on recurrence of Crohn’s disease.
        Lancet. 1989; 2: 1048
        • Tait B.D.
        • d’Apice A.J.F.
        • Morrow L.
        • et al.
        Changes in suppressor cell activity in renal dialysis patients after blood transfusion.
        Transplant Proc. 1984; 16: 995-997
        • Tartter P.I.
        Blood transfusion and infectious complications following colorectal cancer surgery.
        Br J Surg. 1988; 75: 789-792
        • Tartter P.I.
        Blood transfusion and postoperative infections.
        Transfusion. 1989; 29: 456-459
        • Tartter P.I.
        • Burrows L.
        • Kirschner P.
        Perioperative blood transfusion adversely affects prognosis after resection of stage I (subset NO) non-oat cell lung cancer.
        J Thorac Cardio vase Surg. 1984; 88: 659-662
        • Tartter P.I.
        • Burrows L.
        • Papatestas A.E.
        • et al.
        Perioperative blood transfusion has prognostic significance for breast cancer.
        Surgery. 1985; 97: 225-229
        • Tartter P.I.
        • Heimann T.M.
        • Aufses A.H.
        Blood transfusion, skin test reactivity, and lymphocytes in inflammatory bowel disease.
        Am J Surg. 1986; 151: 358-361
        • Tartter P.I.
        • Oriefuss R.M.
        • Malon A.M.
        • et al.
        Relationship of postoperative septic complications and blood transfusions in patients with Crohn’s disease.
        Am J Surg. 1988; 155: 43-48
        • Tartter P.I.
        • Quintero S.
        • Barron O.M.
        Perioperative blood transfusion associated with infectious complications after colorectal cancer operations.
        Am J Surg. 1986; 152: 479-482
        • Tartter P.I.
        • Steinberg B.
        • Barron D.M.
        • et al.
        Transfusion history, T cell subsets and natural killer cytotoxicity in patients with colorectal cancer.
        Vox Sang. 1989; 56: 80-84
        • Tchervenkov J.I.
        • Epstein M.D.
        • Alexander J.W.
        • et al.
        The effect of donor-specific blood transfusions, cyclosporine and dietary prostaglandin precursors on rat cardiac allograft survival.
        Transplantation. 1989; 47: 177-181
        • Terasaki P.I.
        The beneficial transfusion effect on kidney graft survival attributed to clonal deletion.
        Transplantation. 1984; 37: 119-125
        • Toma H.
        • Hayasaka Y.
        • Yasuo M.
        • et al.
        Anti-idiotypic autoantibodies after donor-specific blood transfusions.
        Transplant Proc. 1987; 19: 755-757
        • Tsoukas C.
        • Gervais F.
        • Fuks A.
        • et al.
        Immunologic dysfunction in patients with classic hemophilia receiving lyophilized factor VIII concentrates and cryopoprecipitate.
        Can Med Assoc J. 1983; 129: 713-717
        • Unzeitig J.C.
        • Church J.A.
        • Gomperts E.D.
        • et al.
        Abnormal T-cell subsets and mitogen responses in hemophiliacs exposed to factor concentrate.
        AJDC. 1984; 41: 645-648
        • Van Aken W.G.
        Does perioperative blood transfusion promote tumor growth?.
        Transfusion Med Rev. 1989; 3: 243-252
        • Vliet W.
        • Dock N.
        • Davey F.R.
        Factors in the liquid portion of stored blood inhibit the proliferative response in mixed lymphocyte culture [abstract].
        Transfusion. 1987; 27: 508A
        • Voogt P.J.
        • van de Velde C.J.H.
        • Brand A.
        • et al.
        Perioperative blood transfusion and cancer prognosis: Different effects of blood transfusion on prognosis of colon and breast cancer patients.
        Cancer. 1987; 59: 839-843
        • Wang W.
        • Herrod H.
        • Presbury G.
        • et al.
        Lymphocyte phenotype and function in chronically transfused children with sickle cell disease.
        Am J Hematol. 1985; 20: 31-40
        • Waymack J.P.
        • Fernandes G.
        • Yurt R.W.
        • et al.
        Effect of blood transfusions on immune function. Part VI. Effect on immunologic response to tumor.
        Surgery. 1990; 108: 172-178
        • Waymack J.P.
        • Gallon L.
        • Barcelli U.
        • et al.
        Effect of blood transfusions on immune function. III. Alterations in macrophage arachidonic acid metabolism.
        Arch Surg. 1987; 122: 56-60
        • Waymack J.P.
        • Rapien J.
        • Garnett D.
        • et al.
        Effect of transfusion on immune function in a traumatized animal model.
        Arch Surg. 1986; 121: 50-55
        • Waymack J.P.
        • Warden G.D.
        • Alexander J.W.
        • et al.
        Effect of blood transfusion and anesthesia on resistance to bacterial peritonitis.
        J Surg Res. 1987; 42: 528-535
        • Wearne A.
        • Joshua D.E.
        • Rickard K.A.
        • et al.
        Abnormal T-cell subpopulations in hemophilic patients receiving Factor VIII concentrates from voluntary donors.
        Aust NZ J Med. 1984; 14: 149-153
        • Weiden P.L.
        • Bean M.A.
        • Schultz P.
        Perioperative blood transfusion does not increase risk of colorectal cancer recurrence.
        Cancer. 1987; 60: 870-874
        • Weintrub P.S.
        • Koerper M.A.
        • Addiego J.E.
        • et al.
        Immunologic abnormalities in patients with hemophilia A.
        J Pediatr. 1983; 103: 692-695
        • Williams J.G.
        • Hughes L.E.
        Effect of perioperative blood transfusion on recurrence of Crohn’s disease.
        Lancet. 1989; 2: 131-132
        • Wood M.L.
        • Gottschalk R.
        • Monaco A.P.
        Effect of blood transfusion on IL-2 production.
        Transplantation. 1988; 45: 930-935
        • Yoshimura N.
        • Kahan B.D.
        The immunosuppressive action of suppressor cells from antigen-cyclosporine-treated hosts on renal allograft survival.
        Transplantation. 1985; 40: 384-389
        • Zanella A.
        • Mozzi F.
        • Ferroni P.
        • et al.
        Anti-HTLV-III screening in multitransfused thalassemia patients.
        Vox Sang. 1986; 50: 192
        • Zeller W.J.
        • Scholler P.
        • Roszer W.
        • et al.
        Allogeneic blood transfusions and experimental tumor growth.
        Transplant Proc. 1986; 18: 1448-1449
        • Zanella A.
        • Mozzi F.
        • Ferroni P.
        • et al.
        Anti-HTLV-III screening in multitransfused thalassemia patients.
        Vox Sang. 1986; 50: 192
        • Zeller W.J.
        • Scholler P.
        • Roszer W.
        • et al.
        Allogeneic blood transfusions and experimental tumor growth.
        Transplant Proc. 1986; 18: 1448-1449

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30484-0

      Copyright

      © 1992 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect

      The content on this site is intended for healthcare professionals.


      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the Cookie Preference Center for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties.


      RELX